Identification of a Human IFN⍺2b Variant Active in Mice and its Use in A New Class of Targeted and Conditional IFN-⍺ Therapeutics Poster SITC 2024 Annual Meeting
A novel method for generating regulated cytokine therapeutics: Safety and activity of a conditionally active cLAG3-IL2 in a simple antibody format Poster Keystone Conference 2024
Development of a new class of targeted and conditional cytokine therapeutics using a novel dual-binding antibody-based platform Poster Keystone Conference 2024
A Novel Method for Generating Regulated Cytokine Therapeutics: Safety and Activity of a Conditionally Active cLAG3-IL2 Capable of Delivering IL-2 to LAG-3+ Cells While Remaining Inert on LAG-3- Cells Poster AACR 2024
